Economic Burden Of Adverse Events In Patients Aged ≥65 Years Receiving Treatment For Metastatic Renal Cell Carcinoma (Mrcc)
May 1, 2013, 00:00
10.1016/j.jval.2013.03.647
https://www.valueinhealthjournal.com/article/S1098-3015(13)00718-3/fulltext
Title :
Economic Burden Of Adverse Events In Patients Aged ≥65 Years Receiving Treatment For Metastatic Renal Cell Carcinoma (Mrcc)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00718-3&doi=10.1016/j.jval.2013.03.647
First page :
A133
Section Title :
Cancer
Open access? :
No
Section Order :
197